|
業務類別
|
Biotechnology |
|
業務概覽
|
Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC. |
| 公司地址
| Xintai 5th Road, 23F-3, No. 95, Section 1, Xizhi district, New Taipei, TWN, 221 |
| 電話號碼
| +886 227325205 |
| 傳真號碼
| +886 227325206 |
| 公司網頁
| https://www.healtheverbiotech.com |
| 員工數量
| 27 |
| Ms. Fu-Feng Kuo |
Chairwoman of the Board and Chief Executive Officer |
-- |
15/05/2026 |
| Dr. Fenglin Hsu |
Director and Chief Technology Officer |
-- |
15/05/2026 |
| Ms. Wei Zhang |
Chief Financial Officer |
-- |
15/05/2026 |
|
|
| Mr. Hung-Shu Fan |
Independent Director |
15/05/2026 |
| Ms. Fu-Feng Kuo |
Chairwoman of the Board and Chief Executive Officer |
15/05/2026 |
| Dr. Fenglin Hsu |
Director and Chief Technology Officer |
15/05/2026 |
| Mr. Pang-Chief Chi |
Independent Director |
15/05/2026 |
| Mr. Ming Tsan Hsu |
Independent Director |
15/05/2026 |
|
|
|
|
